Kendall Capital Partners
Funding rounds backed by Kendall Capital Partners.
- Funding disclosed in full
- $43M
- Median round
- $21.5M
- Rounds in calculation
- 2
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Rejuvenate Bio Develops gene therapies for age-related and chronic diseases in animals and humans | $6MStrategic | BiotechUnited States | |||
| Centivax Develops vaccines and therapies for universal protection against diverse targets | $37MUndisclosed | BiotechUnited States |